Together we shape the future of HPB

Innovation to transform HPB outcomes

Provide better outcomes for your HPB patients

HPB team discussions

Boston Scientific is deeply committed to establishing a strong partnership with you, aiming to enhance our understanding of your clinical practice within HPB endoscopy. Through this collaboration, we seek to acquire insights that will enable us shape the future with you by developing solutions that allow you to deliver healthcare to your patients effectively.​​

We aim to empower you in your daily practice by providing the latest clinical data, technological advancements, and solutions to improve patient outcomes and address operational challenges in endoscopy departments.  ​

Tailored solutions for unique patient situations

HCP looking at screen

Our pursuit of innovation aims to reduce the need for surgical intervention and repeat procedures, allowing definitive treatment to be achieved in HPB through minimally invasive approaches.​

Enhancing treatment outcomes through access, diagnosis, therapy and infection prevention

Partnering for innovative HPB transformation with our pioneering R&D team

Boston Scientific has been at the forefront of releasing ground-breaking technologies since 1999, revolutionizing treatment pathways in HPB. ​

​Recognized as one of the 100 most innovative companies in the world by Forbes, Boston Scientific consistently invests approximately $1 billion each year in R&D. With over 100 ongoing global clinical trials, we remain committed to advancing medical knowledge and improving patient care.​

Connect with us:


CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.​​All images owned by Boston Scientific.​